Your browser doesn't support javascript.
loading
Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
Short, Nicholas J; Kantarjian, Hagop M; Sasaki, Koji; Ravandi, Farhad; Ko, Heidi; Cameron Yin, C; Garcia-Manero, Guillermo; Cortes, Jorge E; Garris, Rebecca; O'Brien, Susan M; Patel, Keyur; Khouri, Maria; Thomas, Deborah; Jain, Nitin; Kadia, Tapan M; Daver, Naval G; Benton, Christopher B; Issa, Ghayas C; Konopleva, Marina; Jabbour, Elias.
Affiliation
  • Short NJ; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sasaki K; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ko H; Department of Internal Medicine, The University of Texas Health Science Center, Houston, Texas, USA.
  • Cameron Yin C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cortes JE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Garris R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • O'Brien SM; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California, USA.
  • Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Khouri M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Thomas D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Benton CB; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Issa GC; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 92(3): 238-243, 2017 Mar.
Article in En | MEDLINE | ID: mdl-28006851
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosomes, Human, Pair 9 / Chromosomes, Human, Pair 22 / Antineoplastic Combined Chemotherapy Protocols / Chromosome Aberrations / Protein Kinase Inhibitors / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosomes, Human, Pair 9 / Chromosomes, Human, Pair 22 / Antineoplastic Combined Chemotherapy Protocols / Chromosome Aberrations / Protein Kinase Inhibitors / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States